Generate a structured brief — facts, issues, held, reasoning, and significance — for this case in seconds. Or browse the verbatim judgment via the source links below.
(Interim measures – Biocidal products – Implementing Regulation (EU) 2021/348 – Approval of carbendazim as an existing active substance for use in biocidal products of product-types 7 (film preservatives) and 10 (masonry preservatives) – Application for suspension of operation of a measure – No urgency)
European Commission, represented by R. Lindenthal and M. Farley, acting as Agents,
APPLICATION under Articles 278 and 279 TFEU seeking, first, suspension of operation of Commission Implementing Regulation (EU) 2021/348 of 25 February 2021 approving carbendazim as an existing active substance for use in biocidal products of product-types 7 and 10 (OJ 2021 L 68, p. 174), and, second, the grant of any other interim measures which the General Court considers appropriate,
The first applicant, Troy Chemical Company BV, is a company incorporated under Netherlands law which places biocidal products on the EU market, in particular film preservatives and masonry preservatives containing carbendazim, and the second applicant, Troy Corp., which is a company incorporated under the law of the State of Delaware (United States), is [ confidential ].
Biocidal products are necessary for the control of organisms that are harmful to human or animal health and for the control of organisms that cause damage to natural or manufactured materials. However, biocidal products can pose risks to humans, animals and the environment due to their intrinsic properties and associated use patterns.
Auto-extracted from BAILII. Full structured brief in progress — the source links below give you the verbatim judgment in the meantime.
Put your case reading into practice. The free readiness diagnostic covers SQE1 subjects and highlights where to revise next. No account needed.
Try the free SQE1 diagnosticMultiple official and mirror sources — pick whichever loads cleanly on your network.
[2023] ECHR 69
Common Room
0 comments · About the Common Room →
No comments yet — start the discussion.
Voted-best comments help future students and feed Caselaw's AI study tools.